Innovative Small And Large Molecules Formulations And Higher Drug Loads Across The Life-Cycle

Leveraging best-in-class nanotechnology and expert formulation, advanced particle engineering can significantly improve the performance of both small and large molecule therapeutics. This approach, called NanoImprove, enables innovative formulations and higher drug loads across the life cycle of a compound.

For small molecules, this includes addressing challenging target product profiles by driving superior solubility through the world's smallest nanoparticles, resulting in improved bioavailability and higher drug load. This can lead to smaller, fewer pills for a simplified regimen and improved patient convenience, such as alleviating food effects.

For large molecules like peptides and proteins, unique bio nanoparticles enable higher API concentrations, up to 500 mg/ml, for nonaqueous suspensions and long-acting delivery. Gentle processing delivers solid powders with superior quality compared to spray drying and lyophilization, offering improved stability and flowability for applications like subcutaneous injections and inhalation. Explore the full range of applications, including oral, respiratory, long-acting injectables, ophthalmic, and hydrogels, to see how these nanotechnologies can optimize your drug delivery profile.